[
  {
    "ts": null,
    "headline": "These 3 Stocks Soared Following Strong Quarterly Results",
    "summary": "The 2025 Q1 earnings cycle is in full swing. And these three companies posted results that had investors pleased.",
    "url": "https://finnhub.io/api/news?id=539b63f29600610078bd4d097cf68c26c381ca990d6112e9abccdad0499d87d3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746132540,
      "headline": "These 3 Stocks Soared Following Strong Quarterly Results",
      "id": 134184559,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The 2025 Q1 earnings cycle is in full swing. And these three companies posted results that had investors pleased.",
      "url": "https://finnhub.io/api/news?id=539b63f29600610078bd4d097cf68c26c381ca990d6112e9abccdad0499d87d3"
    }
  },
  {
    "ts": null,
    "headline": "SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts",
    "summary": "Despite the strength in Pounce thrombectomy device platforms and strong IVD product sales, Surmodics' second-quarter fiscal 2025 results show weak performance.",
    "url": "https://finnhub.io/api/news?id=8c18f46b3a587e067d3cb92779c1e3757102bb0f886e970465e000afc5f7d131",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117960,
      "headline": "SRDX Stock Down Following Q2 Earnings Miss, Gross Margin Contracts",
      "id": 134184924,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Despite the strength in Pounce thrombectomy device platforms and strong IVD product sales, Surmodics' second-quarter fiscal 2025 results show weak performance.",
      "url": "https://finnhub.io/api/news?id=8c18f46b3a587e067d3cb92779c1e3757102bb0f886e970465e000afc5f7d131"
    }
  },
  {
    "ts": null,
    "headline": "OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands",
    "summary": "Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.",
    "url": "https://finnhub.io/api/news?id=1791fd14d6f78a86c53c262247394ab77b50bc8325868b90500ef70997132e85",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746117780,
      "headline": "OPK Stock Slips Following Q1 Earnings Miss, Gross Margin Expands",
      "id": 134184925,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Despite strength in OPKO Health's revenues from the transfer of intellectual property, the company reports an overall soft first-quarter 2025 performance.",
      "url": "https://finnhub.io/api/news?id=1791fd14d6f78a86c53c262247394ab77b50bc8325868b90500ef70997132e85"
    }
  },
  {
    "ts": null,
    "headline": "BD Stock Falls in Pre-Market Despite Q2 Earnings Beat, Margins Down",
    "summary": "BDX's overall topline in the second quarter of fiscal 2025 continues to benefit from strength in its Medical segment and geographic performances.",
    "url": "https://finnhub.io/api/news?id=c07b610e80b4053593e33f80873a46d7da697e782e8ec9a21ec5442a5c938ab9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746113940,
      "headline": "BD Stock Falls in Pre-Market Despite Q2 Earnings Beat, Margins Down",
      "id": 134173626,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BDX's overall topline in the second quarter of fiscal 2025 continues to benefit from strength in its Medical segment and geographic performances.",
      "url": "https://finnhub.io/api/news?id=c07b610e80b4053593e33f80873a46d7da697e782e8ec9a21ec5442a5c938ab9"
    }
  },
  {
    "ts": null,
    "headline": "CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up",
    "summary": "CVS Health delivers earnings and revenue beat in the first quarter of 2025.",
    "url": "https://finnhub.io/api/news?id=3d8e8d71f7518ab394c631bf44dab0c98777feee2b2d47c245c814481eb5b27b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746105300,
      "headline": "CVS Q1 Earnings & Revenues Beat, '25 EPS View Raised, Stock Up",
      "id": 134173627,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "CVS Health delivers earnings and revenue beat in the first quarter of 2025.",
      "url": "https://finnhub.io/api/news?id=3d8e8d71f7518ab394c631bf44dab0c98777feee2b2d47c245c814481eb5b27b"
    }
  },
  {
    "ts": null,
    "headline": "Boston Scientific announces upcoming investor conference schedule",
    "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.",
    "url": "https://finnhub.io/api/news?id=85ba7a0fd97c0d46dcc74f949e89fcefacd6a06ffe45f23cc3db71b14dbb0b45",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746100800,
      "headline": "Boston Scientific announces upcoming investor conference schedule",
      "id": 134173628,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific Corporation (NYSE: BSX) will participate in two upcoming investor conferences in May.",
      "url": "https://finnhub.io/api/news?id=85ba7a0fd97c0d46dcc74f949e89fcefacd6a06ffe45f23cc3db71b14dbb0b45"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Boston Scientific Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08",
    "summary": "Presenter SpeechTravis Steed All right. Good morning, everybody. Travis Steed, the medical device analyst at Bank of America. And first, up to the BofA conference, welcome to have Boston",
    "url": "https://finnhub.io/api/news?id=1fd3023b26a7ad588a104e4160b1ff096e6002c6ec8ae7b76dff09a9bd42c273",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746086400,
      "headline": "Transcript : Boston Scientific Corporation Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08",
      "id": 134400721,
      "image": "",
      "related": "BSX",
      "source": "Finnhub",
      "summary": "Presenter SpeechTravis Steed All right. Good morning, everybody. Travis Steed, the medical device analyst at Bank of America. And first, up to the BofA conference, welcome to have Boston",
      "url": "https://finnhub.io/api/news?id=1fd3023b26a7ad588a104e4160b1ff096e6002c6ec8ae7b76dff09a9bd42c273"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?",
    "summary": "We recently published a list of How Did Jim Cramer’s 12 Bold Predictions Play Out?. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer recently discussed. During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in […]",
    "url": "https://finnhub.io/api/news?id=47a262b5b264883dd5f120c2ccfeb758d1ea185b1612ceeec873b03e1fce5c0d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746057791,
      "headline": "Edwards Lifesciences Corporation (EW): Jim Cramer Says It’s a Hold — But Is Boston Scientific Now His Favorite?",
      "id": 134166066,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "We recently published a list of How Did Jim Cramer’s 12 Bold Predictions Play Out?. In this article, we are going to take a look at where Edwards Lifesciences Corporation (NYSE:EW) stands against other stocks that Jim Cramer recently discussed. During the most recent episode of Mad Money, Jim Cramer revisited the recent turbulence in […]",
      "url": "https://finnhub.io/api/news?id=47a262b5b264883dd5f120c2ccfeb758d1ea185b1612ceeec873b03e1fce5c0d"
    }
  }
]